View Main Condition: Leukemia
Mikkael Sekeres is a Hematologist Oncology specialist and a Hematologist in Miami, Florida. Sekeres has been practicing medicine for over 27 years and is rated as an Elite expert by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 25 other conditions, according to our data. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Sekeres is currently accepting new patients.
Lionel Ades practices in Paris, France. Ades is rated as an Elite expert by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 13 other conditions, according to our data. His top areas of expertise are Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML), Leukemia, and Bone Marrow Transplant.
Douglas Faller is a Hematologist in Boston, Massachusetts. Faller has been practicing medicine for over 44 years and is rated as an Elite expert by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 6 other conditions, according to our data. His top areas of expertise are Acute Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myelodysplastic Syndrome (MDS), and Acute Myeloid Leukemia (AML).
Summary: This phase I/II trial investigates the side effects and best dose of venetoclax when given together with azacitidine and to see how well it works in treating patients with high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia that has come back (relapsed) or has not responded to treatment (refractory). Venetoclax may stop the growth of cancer cells by blocking some of the enzymes n...
Summary: This phase II trial studies how well clofarabine and melphalan before a donor stem cell transplant works in treating patients with a decrease in or disappearance of signs and symptoms of myelodysplasia or acute leukemia (disease is in remission), or chronic myelomonocytic leukemia. Giving chemotherapy, such as clofarabine and melphalan, before a donor stem cell transplant helps stop the growth of ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center